Yeomans Consulting Group’s Verona Pharma VRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$297K Sell
3,287
-515
2025
Q1
$241K Buy
+3,802